迈博药业-B(02181.HK)拟8月28日举行董事会会议批准中期业绩

Core Viewpoint - The company, Maibo Pharmaceutical-B (02181.HK), has announced a board meeting scheduled for August 28, 2025, to consider and approve its interim results for the six months ending June 30, 2025, along with addressing other matters [1]. Group 1 - The board meeting will take place on August 28, 2025 [1] - The meeting will focus on the approval of the interim results for the six months ending June 30, 2025 [1] - Other matters will also be addressed during the board meeting [1]